United Therapeutics (NASDAQ: UTHR) has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PPRV) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE